Discover the full directors' dealings record of Acreage Holdings, Inc., a publicly traded company based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, Acreage Holdings, Inc. has logged 41 public disclosures. The latest transaction was disclosed on 12 April 2022 — Cession. Among the most active insiders: Doherty James A III. All data is openly available.
25 of 41 declarations
Acreage Holdings, Inc. is a U.S.-based multi-state cannabis operator built around a vertically integrated model that spans cultivation, processing, branded product manufacturing, wholesale distribution, and retail dispensing. In practical terms, the company aims to control the full “seed-to-sale” chain so it can manage product consistency, quality, and the consumer experience across its footprint. Acreage says it was founded in 2011; its SEC filings further indicate that the current corporate structure was formed in 2014 and later redomiciled and renamed Acreage Holdings, Inc. in 2018. ([acreageholdings.com](https://www.acreageholdings.com/about-us/?utm_source=openai)) From a market perspective, Acreage has been associated with North American cannabis listings and has cited Canadian/U.S. market venues such as the CSE and OTCQX in company disclosures and announcements. For U.S. equity investors, the more important takeaway is that Acreage has been a U.S.-focused issuer with significant SEC reporting history, which places it within the universe of U.S.-linked public equities followed for corporate actions, insider activity, and regulatory developments. Given the cannabis industry’s structure in the United States, the stock has also been exposed to elevated legal and policy risk. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1762359/000176235924000023/acrg-20231231.htm?utm_source=openai)) Acreage’s core business lines are cultivation, processing, retail, and consumer brands. The company markets products under brands such as The Botanist, positioned around a trusted, premium-yet-accessible consumer experience, and Superflux, which focuses on concentrates, vapes, and premium flower. In its latest annual report available through the SEC, Acreage stated that it operated in eight states and owned and operated 23 dispensaries, with a footprint including Ohio, Maine, New York, New Jersey, Connecticut, Massachusetts, and Illinois. That geographic spread gives it exposure to both medical and adult-use markets, depending on state rules. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1762359/000176235924000023/acrg-20231231.htm?utm_source=openai)) Competitive positioning is typical of a U.S. multi-state operator: fragmented market structure, local licensing barriers, and intense competition for retail locations, cultivation capacity, and shelf space. Acreage’s relative strengths have historically been its vertical integration, brand development, and ability to tailor products to state-specific demand. The company emphasizes operational excellence, product consistency, and a broad portfolio designed to serve new and existing cannabis consumers. ([acreageholdings.com](https://www.acreageholdings.com/?utm_source=openai)) Recent corporate developments are especially important. In June 2024, Acreage announced corporate transactions that included the exercise of the call option to acquire its fixed shares, effectively moving the Canopy USA transaction forward. In December 2024, Acreage confirmed the completion of Canopy USA’s acquisition of Acreage. Prior to that closing, management also highlighted a growth push in key states such as New Jersey, Illinois, Connecticut, and Ohio. For investors, Acreage is best understood as a cannabis operating platform that became part of a broader consolidation story, while still reflecting the underlying regulatory complexity of the U.S. cannabis market. ([globenewswire.com](https://www.globenewswire.com/news-release/2024/06/04/2893023/0/en/acreage-announces-corporate-transactions.html?utm_source=openai))